Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fayez Alghofaili

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Saudi Journal of Biological Sciences|December 6, 2021
Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi ArabiaWael Alturaiki, Ayman Mubarak, Sajad Ahmad Mir, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or FavipiravirBandar Alosaimi, Huda M Alshanbari, Muath Alturaiqy, et al.
International Journal of Environmental Research and Public Health|July 2, 2021
SARS-CoV-2: An Overview of Virus Genetics, Transmission, and ImmunopathogenesisMohamed A Farrag, Haitham M Amer, Rauf Bhat, et al.
International Journal of Rheumatic Diseases|June 24, 2022
Assessment of IL-1β, IL-6, TNF-α, IL-8, and CCL 5 levels in newly diagnosed Saudi patients with rheumatoid arthritisWael Alturaiki, Abdulaziz Alhamad, Muath Alturaiqy, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Saudi Journal of Biological Sciences|December 6, 2021
Plasma levels of BAFF and APRIL are elevated in patients with asthma in Saudi ArabiaWael Alturaiki, Ayman Mubarak, Sajad Ahmad Mir, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or FavipiravirBandar Alosaimi, Huda M Alshanbari, Muath Alturaiqy, et al.
International Journal of Environmental Research and Public Health|July 2, 2021
SARS-CoV-2: An Overview of Virus Genetics, Transmission, and ImmunopathogenesisMohamed A Farrag, Haitham M Amer, Rauf Bhat, et al.
International Journal of Rheumatic Diseases|June 24, 2022
Assessment of IL-1β, IL-6, TNF-α, IL-8, and CCL 5 levels in newly diagnosed Saudi patients with rheumatoid arthritisWael Alturaiki, Abdulaziz Alhamad, Muath Alturaiqy, et al.
Pageof 2